2018
DOI: 10.1016/j.prp.2018.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive expression analysis of TNF-related apoptosis-inducing ligand and its receptors in colorectal cancer: Correlation with MAPK alterations and clinicopathological associations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…The sequences of the primers for BRAF, KRAS have been published previously (49). For MSI status, a panel of mononucleotide microsatellite markers (BAT25, BAT26, NR21, NR24) was analysed by HRM analysis, performed as reported previously (50,51).…”
Section: Methodsmentioning
confidence: 99%
“…The sequences of the primers for BRAF, KRAS have been published previously (49). For MSI status, a panel of mononucleotide microsatellite markers (BAT25, BAT26, NR21, NR24) was analysed by HRM analysis, performed as reported previously (50,51).…”
Section: Methodsmentioning
confidence: 99%
“…Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers. TNF-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein and binds its receptors TRAIL-R1 and TRAIL-R2, which in turn recruit downstream adaptor proteins via its intracellular death domain (DD) and activate the intrinsic apoptotic pathway triggering selective neoplastic cell apoptosis [36][37]. This is regulated by non-functional TRAIL receptors, TRAIL-R3 and TRAIL-R4 that are devoid of a cytoplasmic tail or carry a truncated intracellular DD, respectively, and block TRAIL-mediated apoptosis [38][39].…”
Section: Discussionmentioning
confidence: 99%
“…The extracted DNA was quantitated on a Picodrop microliter spectrophotometer. Samples were screened in duplicates for mutations of KRAS, NRAS , and BRAF , using a real-time polymerase chain reaction approach followed by high-resolution melting analysis on a Light Cycler 480 (Roche Diagnostics, GmbH, Germany) 25. Polymerase chain reaction products positive by high-resolution melting analysis were purified and subjected to Sanger sequencing and/or pyrosequencing.…”
Section: Methodsmentioning
confidence: 99%